Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial.
Khan MS, Anker SD, Filippatos G, Ferreira JP, Pocock SJ, Januzzi JL, Chopra VK, Piña IL, Böhm M, Ponikowski P, Verma S, Brueckmann M, Vedin O, Peil B, Zannad F, Packer M, Butler J.
Khan MS, et al.
J Card Fail. 2023 Oct;29(10):1345-1354. doi: 10.1016/j.cardfail.2023.06.024. Epub 2023 Aug 8.
J Card Fail. 2023.
PMID: 37558088
Free article.